Sustainabilitycategory· May 1, 2025 Medical device maker Becton Dickinson cuts 2025 profit forecast on potential tariff hit Medical device maker Becton Dickinson lowered its annual profit ...

In this article, we are going to take a look at where Becton, Dickinson, and Company (NYSE:BDX) stands against other best falling stocks to buy according to analysts. Over the past two years ...

AMHERST — The Emily Dickinson Museum will celebrate on Tuesday the $1 million reconstruction of a 170-year-old carriage house that once stood on its Amherst property and is slated to become the ...

As of April 24, 2025, the average one-year price target for Becton, Dickinson and is $275.44/share. The forecasts range from a low of $247.45 to a high of $337.58.

On Friday, Piper Sandler adjusted its stance on Becton Dickinson (NYSE:BDX) shares, downgrading the company from Overweight to Neutral and slashing the price target to $185.00 from the previous ...

On Friday, Becton Dickinson and Company (NYSE:BDX) experienced a change in its stock rating as Goldman Sachs (NYSE:GS) analysts downgraded the company from "Buy" to "Neutral." The firm also adjusted ...

On Friday, Raymond James made a significant adjustment to its outlook on Becton Dickinson (NYSE:BDX), downgrading the medical technology company’s stock from Outperform to Market Perform.

On Friday, Becton Dickinson and Company (NYSE:BDX) experienced a change in its stock rating as Goldman Sachs analysts downgraded the company from "Buy" to "Neutral." The firm also adjusted the ...

The latest price target for Becton Dickinson (NYSE:BDX) was reported by Morgan Stanley on May 6, 2025. The analyst firm set a price target for $196.00 expecting BDX to rise to within 12 months (a ...

Sustainalytics’ Controversies Research identifies companies involved in incidents and events that may negatively impact stakeholders, the environment or the company’s operations. Controversies ...

Becton Dickinson (BDX) came out with quarterly earnings of $3.35 per share, beating the Zacks Consensus Estimate of $3.28 per share. This compares to earnings of $3.17 per share a year ago.